SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ARS Pharma (SPRY) Gains China Approval for Neffy, Roth Reiterates Buy Rating [Yahoo! Finance]
ARS Pharmaceuticals announces NMPA approval for neffy 2 mg [Yahoo! Finance]
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis) [Yahoo! Finance]
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts [Yahoo! Finance]
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Scott Kathleen D.
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Karas Eric
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Fitzpatrick Alexander A
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Dorsey Brian
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Chakma Justin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.